作者: Guang-He Fei , Wei Jia , Jie-Gui Hu , Xian-Wei Hu
DOI: 10.2147/OTT.S84636
关键词: Lung cancer 、 Cytokine 、 Survival rate 、 Gene 、 Biological regulation 、 Gene polymorphism 、 Promoter 、 Bioinformatics 、 Medicine 、 Interleukin 6 、 Cancer research
摘要: Background Lung cancer is one of the most commonly diagnosed clinical diseases. IL-6 a multifunctional cytokine that related to chemotactic factors and tumor biological regulation. −174G/C polymorphism in promoter region gene single-nucleotide −174 position change from G C. However, relationship between prognosis lung elusive. Therefore, aim this study was evaluate effect on patients with non-small-cell (NSCLC).